Human embryonic-derived hematopoietic repopulating cells require distinct factors to sustain in vivo repopulating function

Experimental Hematology

Volumn 30, Issue 6, 2002, Pages 598-605

  Murdoch, Barbara ^a,c   Gallacher, Lisa ^a   Chadwick, Kristin ^a   Fellows, Fraser ^b   Bhatia, Mickie ^a,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; ONCOSTATIN M; STEM CELL FACTOR;

ARTICLE; CELL COMPOSITION; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO CELL; EVALUATION; FETUS; FETUS BLOOD; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; STEM CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL SEPARATION; COLONY-FORMING UNITS ASSAY; EMBRYO; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-6; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036284774     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00793-2     Document Type: Article

References (19)

1. Identification of novel circulating human embryonic blood stem cells
2. Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy
3. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
4. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
5. Ex vivo manipulation of hematopoietic stem and progenitor cells
6. Prospects for in utero human gene therapy
7. Assay of human stem cells by repopulation of NOD/SCID mice
8. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
9. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
10. Self-renewal of primitive human hematopoietic cells (long-term culture-initiating cells) in vitro and their expansion in defined medium
11. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region
12. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer
13. The flt3 ligand: A hematopoietic stem cell factor whose activities are distinct from steel factor
14. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells
15. Ontogeny-related changes in proliferative potential of human hematopoietic cells
16. Interleukin-3 or interleukin-1 abrogates the reconstituting ability of hematopoietic stem cells
17. In vitro expansion of hematopoietic stem cells
18. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: Transduction of the negative signals by βc and βIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor
19. Humoral regulation of hematopoietic stem cells